LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
73.76 771.67 9293 10851 0.8564 0.9203
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.02 771.67 9733 11106 0.8763 0.9325
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
76.02 771.67 9459 11106 0.8516 0.9182
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
78.25 771.67 9988 11367 0.8786 0.9344
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
78.25 771.67 9622 11367 0.8464 0.9159
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
80.48 771.67 10260 11685 0.8781 0.9347
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
80.48 771.67 9738 11685 0.8334 0.9092
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
82.69 771.67 10613 11974 0.8863 0.9399
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
82.69 771.67 10026 11974 0.8373 0.9122
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
84.92 771.67 10875 12266 0.8865 0.9406
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
84.92 771.67 10184 12266 0.8302 0.9089
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
87.14 771.67 11203 12592 0.8897 0.9428
MN20160304_L01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
87.14 771.67 10289 12592 0.8171 0.9022
MN20160304_L01
D12
MCF 10A-H2B-mCherry Trametinib
0.001
2.49 771.67 839 867 0.9669 0.6391
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
2.49 771.67 952 867 1.0971 2.4572
MN20160304_L01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
4.71 771.67 934 956 0.9766 0.8528
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
4.71 771.67 1062 956 1.1104 1.8053
MN20160304_L01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
6.94 771.67 1027 1045 0.9827 0.9216
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
6.94 771.67 1134 1045 1.0850 1.4100
MN20160304_L01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
9.16 771.67 1113 1138 0.9776 0.9209
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
9.16 771.67 1240 1138 1.0892 1.3288
MN20160304_L01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
11.56 771.67 1294 1280 1.0104 1.0286
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
11.56 771.67 1405 1280 1.0971 1.2705
MN20160304_L01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
13.78 771.67 1426 1459 0.9769 0.9498
MN20160304_L01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
13.78 771.67 1606 1459 1.1002 1.2188
MN20160304_L01
M13